Dexamethasone regulates the β-adrenergic receptor subtype expressed by 3T3-L1 preadipocytes and adipocytes

E. Lai, O. M. Rosen, C. S. Rubin

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

The subtype of the β-adrenergic receptor expressed in 3T3-L1 preadipocytes and adipocytes differentiated with dexamethasone and methylisobutylxanthine was determined by comparing the affinity of the receptors for epinephrine, norepinephrine, and β-1 and β-2 selective drugs. Receptors in preadipocyte membranes exhibited the same affinity for epinephrine and norepinephrine and bound practolol, a β-1 selective antagonist, 8-fold more avidly than adipocyte receptors. In contrast, adipocyte β-receptors had a 10-fold higher affinity for epinephrine than for norepinephrine and complexed the β-2 selective agonist zinterol with a 20-fold higher affinity than preadipocyte receptors. Hofstee plots and computer analyses of the binding data revealed that the populations of β-1 receptors in preadipocytes and β-2 receptors in adipocytes were nearly homogeneous. Preliminary characterizations of the β-receptor phenotype in (nondifferentiating) 3T3-C2 cells treated with dexamethasone and methylisobutylxanthine and 3T3-422A adipocytes differentiated with insulin indicated that the expression of β-2 receptors was not correlated with differentiation, but rather with exposure of the cells to dexamethasone and methylisobutylxanthine. The regulator of β-receptor subtype was identified as the glucocorticoid analog, dexamethasone, by employing 3T3-L1 adipocytes which were stimulated to differentiate with methylisobutylxanthine and insulin. Detailed binding studies showed that under these conditions the adipocyte receptors retain β-1 character. Subsequent treatment with 0.5 μM dexamethasone promoted the loss of β-1 receptors, the appearance of β-2 receptors, and a net 2- to 3-fold increase in the number of β-receptors. Dexamethasone effected a complete switch from β-1 to β-2 subtype at concentrations as low as 2.5 nM while other steroids were effective below a concentration of 10 μM.

Original languageEnglish (US)
Pages (from-to)6691-6696
Number of pages6
JournalJournal of Biological Chemistry
Volume257
Issue number12
StatePublished - 1982

Fingerprint

Adipocytes
Adrenergic Receptors
Dexamethasone
Norepinephrine
Epinephrine
Practolol
Insulin
3T3 Cells
Glucocorticoids
Steroids
Switches
Membranes
Phenotype
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Biochemistry

Cite this

Dexamethasone regulates the β-adrenergic receptor subtype expressed by 3T3-L1 preadipocytes and adipocytes. / Lai, E.; Rosen, O. M.; Rubin, C. S.

In: Journal of Biological Chemistry, Vol. 257, No. 12, 1982, p. 6691-6696.

Research output: Contribution to journalArticle

@article{1b2fcdc3f218420c8a67da1fea0e4e84,
title = "Dexamethasone regulates the β-adrenergic receptor subtype expressed by 3T3-L1 preadipocytes and adipocytes",
abstract = "The subtype of the β-adrenergic receptor expressed in 3T3-L1 preadipocytes and adipocytes differentiated with dexamethasone and methylisobutylxanthine was determined by comparing the affinity of the receptors for epinephrine, norepinephrine, and β-1 and β-2 selective drugs. Receptors in preadipocyte membranes exhibited the same affinity for epinephrine and norepinephrine and bound practolol, a β-1 selective antagonist, 8-fold more avidly than adipocyte receptors. In contrast, adipocyte β-receptors had a 10-fold higher affinity for epinephrine than for norepinephrine and complexed the β-2 selective agonist zinterol with a 20-fold higher affinity than preadipocyte receptors. Hofstee plots and computer analyses of the binding data revealed that the populations of β-1 receptors in preadipocytes and β-2 receptors in adipocytes were nearly homogeneous. Preliminary characterizations of the β-receptor phenotype in (nondifferentiating) 3T3-C2 cells treated with dexamethasone and methylisobutylxanthine and 3T3-422A adipocytes differentiated with insulin indicated that the expression of β-2 receptors was not correlated with differentiation, but rather with exposure of the cells to dexamethasone and methylisobutylxanthine. The regulator of β-receptor subtype was identified as the glucocorticoid analog, dexamethasone, by employing 3T3-L1 adipocytes which were stimulated to differentiate with methylisobutylxanthine and insulin. Detailed binding studies showed that under these conditions the adipocyte receptors retain β-1 character. Subsequent treatment with 0.5 μM dexamethasone promoted the loss of β-1 receptors, the appearance of β-2 receptors, and a net 2- to 3-fold increase in the number of β-receptors. Dexamethasone effected a complete switch from β-1 to β-2 subtype at concentrations as low as 2.5 nM while other steroids were effective below a concentration of 10 μM.",
author = "E. Lai and Rosen, {O. M.} and Rubin, {C. S.}",
year = "1982",
language = "English (US)",
volume = "257",
pages = "6691--6696",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "12",

}

TY - JOUR

T1 - Dexamethasone regulates the β-adrenergic receptor subtype expressed by 3T3-L1 preadipocytes and adipocytes

AU - Lai, E.

AU - Rosen, O. M.

AU - Rubin, C. S.

PY - 1982

Y1 - 1982

N2 - The subtype of the β-adrenergic receptor expressed in 3T3-L1 preadipocytes and adipocytes differentiated with dexamethasone and methylisobutylxanthine was determined by comparing the affinity of the receptors for epinephrine, norepinephrine, and β-1 and β-2 selective drugs. Receptors in preadipocyte membranes exhibited the same affinity for epinephrine and norepinephrine and bound practolol, a β-1 selective antagonist, 8-fold more avidly than adipocyte receptors. In contrast, adipocyte β-receptors had a 10-fold higher affinity for epinephrine than for norepinephrine and complexed the β-2 selective agonist zinterol with a 20-fold higher affinity than preadipocyte receptors. Hofstee plots and computer analyses of the binding data revealed that the populations of β-1 receptors in preadipocytes and β-2 receptors in adipocytes were nearly homogeneous. Preliminary characterizations of the β-receptor phenotype in (nondifferentiating) 3T3-C2 cells treated with dexamethasone and methylisobutylxanthine and 3T3-422A adipocytes differentiated with insulin indicated that the expression of β-2 receptors was not correlated with differentiation, but rather with exposure of the cells to dexamethasone and methylisobutylxanthine. The regulator of β-receptor subtype was identified as the glucocorticoid analog, dexamethasone, by employing 3T3-L1 adipocytes which were stimulated to differentiate with methylisobutylxanthine and insulin. Detailed binding studies showed that under these conditions the adipocyte receptors retain β-1 character. Subsequent treatment with 0.5 μM dexamethasone promoted the loss of β-1 receptors, the appearance of β-2 receptors, and a net 2- to 3-fold increase in the number of β-receptors. Dexamethasone effected a complete switch from β-1 to β-2 subtype at concentrations as low as 2.5 nM while other steroids were effective below a concentration of 10 μM.

AB - The subtype of the β-adrenergic receptor expressed in 3T3-L1 preadipocytes and adipocytes differentiated with dexamethasone and methylisobutylxanthine was determined by comparing the affinity of the receptors for epinephrine, norepinephrine, and β-1 and β-2 selective drugs. Receptors in preadipocyte membranes exhibited the same affinity for epinephrine and norepinephrine and bound practolol, a β-1 selective antagonist, 8-fold more avidly than adipocyte receptors. In contrast, adipocyte β-receptors had a 10-fold higher affinity for epinephrine than for norepinephrine and complexed the β-2 selective agonist zinterol with a 20-fold higher affinity than preadipocyte receptors. Hofstee plots and computer analyses of the binding data revealed that the populations of β-1 receptors in preadipocytes and β-2 receptors in adipocytes were nearly homogeneous. Preliminary characterizations of the β-receptor phenotype in (nondifferentiating) 3T3-C2 cells treated with dexamethasone and methylisobutylxanthine and 3T3-422A adipocytes differentiated with insulin indicated that the expression of β-2 receptors was not correlated with differentiation, but rather with exposure of the cells to dexamethasone and methylisobutylxanthine. The regulator of β-receptor subtype was identified as the glucocorticoid analog, dexamethasone, by employing 3T3-L1 adipocytes which were stimulated to differentiate with methylisobutylxanthine and insulin. Detailed binding studies showed that under these conditions the adipocyte receptors retain β-1 character. Subsequent treatment with 0.5 μM dexamethasone promoted the loss of β-1 receptors, the appearance of β-2 receptors, and a net 2- to 3-fold increase in the number of β-receptors. Dexamethasone effected a complete switch from β-1 to β-2 subtype at concentrations as low as 2.5 nM while other steroids were effective below a concentration of 10 μM.

UR - http://www.scopus.com/inward/record.url?scp=0020326568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020326568&partnerID=8YFLogxK

M3 - Article

C2 - 6123502

AN - SCOPUS:0020326568

VL - 257

SP - 6691

EP - 6696

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 12

ER -